No evidence that GATA3 rs570613 SNP modifies breast cancer risk

Breast Cancer Research and Treatment

Volumn 117, Issue 2, 2009, Pages 371-379

  Johnatty, Sharon E ^a   Couch, Fergus J ^b   Fredericksen, Zachary ^b   Tarrell, Robert ^b   Spurdle, Amanda B ^a   Beesley, Jonathan ^a   Chen, Xiaoqing ^a   Gschwantler Kaulich, Daphne ^c,d,e,f   Singer, Christian F ^c,d,e,f   Fuerhauser, Christine ^c,d,e,f   Fink Retter, Anneliese ^c,d,e,f   Domchek, Susan M ^c,d,e,g   Nathanson, Katherine L ^c,d,e,g   Pankratz, Vernon S ^b,c,d,e   Lindor, Noralane M ^b,c,d,e   Godwin, Andrew K ^c,d,e,h   Caligo, Maria A ^c,d,e,i   Hopper, John ^c,d,e,j   Southey, Melissa C ^c,d,e,j   Giles, Graham G ^c,d,e,k   Justenhoven, Christina ^c,d,e,l,m   Brauch, Hiltrud ^c,d,e,l,m   Hamann, Ute ^c,d,e,n   Ko, Yon Dschun ^c,d,e,o   Heikkinen, Tuomas ^c,d,e,p   Aaltonen, Kirsimari ^c,d,e,p   Aittomäki, Kristiina ^c,d,e,p   Blomqvist, Carl ^c,d,e,p   Nevanlinna, Heli ^c,d,e,p   Hall, Per ^c,d,e,q   Czene, Kamila ^c,d,e,q   Liu, Jianjun ^c,d,e,r   Peock, Susan ^c,d,e,s   Cook, Margaret ^c,d,e,s   Platte, Radka ^c,d,e,s   Gareth Evans, D ^c,d,e,t   Lalloo, Fiona ^c,d,e,t   Eeles, Rosalind ^c,d,e,u   Pichert, Gabriella ^c,d,e,v   Eccles, Diana ^c,d,e,w   Davidson, Rosemarie ^c,d,e,x   Cole, Trevor ^c,d,e,y   Cook, Jackie ^c,d,e,z   Douglas, Fiona ^c,d,e,aa   Chu, Carol ^c,d,e,ab   Hodgson, Shirley ^c,d,e,ac   Paterson, Joan ^c,d,e,ad   Hogervorst, Frans B L ^c,d,e,ae   Rookus, Matti A ^c,d,e,ae   Seynaeve, Caroline ^c,d,e,af   Wijnen, Juul ^c,d,e,ag   Vreeswijk, Maaike ^c,d,e,ag   Ligtenberg, Marjolijn ^c,d,e,ah   Van Der Luijt, Rob B ^c,d,e,ai   Van Os, Theo A M ^c,d,e,aj   Gille, Hans J P ^c,d,e,ak   Blok, Marinus J ^c,d,e,al   Issacs, Claudine ^c,d,e,am   Humphreys, Manjeet K ^c,d,e,s   McGuffog, Lesley ^c,d,e,s   Healey, Sue ^a,c,d,e   Sinilnikova, Olga ^c,d,e,an,ao   Antoniou, Antonis C ^c,d,e,s   Easton, Douglas F ^c,d,e,s   Chenevix Trench, Georgia ^a,c,d,e   more..

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Mayo Clinic   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ UNIVERSITY OF PISA   (Italy)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k CANCER EPIDEMIOLOGY CENTRE   (Australia)

^l DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^m UNIVERSITY OF TÜBINGEN   (Germany)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o Johanniter Krankenhaus   (Germany)

^p HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^q KAROLINSKA INSTITUTE   (Sweden)

^r GENOME INSTITUTE OF SINGAPORE   (Singapore)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t ST MARY S HOSPITAL   (United Kingdom)

^u INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^v GUY S HOSPITAL   (United Kingdom)

^w PRINCESS ANNE HOSPITAL   (United Kingdom)

^x Ferguson Smith Centre for Clinical Genetics   (United Kingdom)

^y BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^z SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^aa NEWCASTLE UNIVERSITY   (United Kingdom)

^ab Yorkshire Regional Genetics Service   (United Kingdom)

^ac ST GEORGE S HOSPITAL   (United Kingdom)

^ad ADDENBROOKE S HOSPITAL   (United Kingdom)

^ae NETHERLANDS CANCER INSTITUTE   (Netherlands)

^af ERASMUS MEDICAL CENTER   (Netherlands)

^ag LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ah RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ai UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aj ACADEMIC MEDICAL CENTER   (Netherlands)

^ak VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^al MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^am GEORGETOWN UNIVERSITY   (United States)

^an HOSPICES CIVILS DE LYON   (France)

^ao UNIVERSITÉ DE LYON   (France)

more..

Author keywords

BRCA1 and BRCA2; Breast cancer; GATA3; Polymorphism; Risk

Indexed keywords

ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ADULT; ALLELE; ARTICLE; BRCA2 ONCOGENE; BREAST CANCER; CANCER RISK; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GATA3 GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MAMMARY GLAND; MORPHOGENESIS; NORWAY; ONCOGENE; POLAND; PRIORITY JOURNAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL;

BREAST NEOPLASMS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 68949092457     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0257-1     Document Type: Article

References (20)

1. RK Patient JD McGhee 2002 The GATA family (vertebrates and invertebrates) Curr Opin Genet Dev 12 416 422 10.1016/S0959-437X(02)00319-2
2. H Kouros-Mehr EM Slorach MD Sternlicht Z Werb 2006 GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 1041 1055 10.1016/j.cell.2006.09.048
3. ML Asselin-Labat KD Sutherland H Barker R Thomas M Shackleton NC Forrest L Hartley L Robb FG Grosveld J van der Wees GJ Lindeman JE Visvader 2007 Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 201 209 10.1038/ncb1530
4. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093
5. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen M van de Rijn SS Jeffrey T Thorsen H Quist JC Matese PO Brown D Botstein P Eystein Lonning AL Borresen-Dale 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 10.1073/pnas.191367098
6. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398 10.1073/pnas.1732912100
7. RV Hoch DA Thompson RJ Baker RJ Weigel 1999 GATA-3 is expressed in association with estrogen receptor in breast cancer Int J Cancer 84 122 128 10.1002/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S
8. M van de Rijn CM Perou R Tibshirani P Haas O Kallioniemi J Kononen J Torhorst G Sauter M Zuber OR Kochli F Mross H Dieterich R Seitz D Ross D Botstein P Brown 2002 Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome Am J Pathol 161 1991 1996
9. R Mehra S Varambally L Ding R Shen MS Sabel D Ghosh AM Chinnaiyan CG Kleer 2005 Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis Cancer Res 65 11259 11264 10.1158/0008-5472.CAN-05-2495
10. P Parikh JP Palazzo LJ Rose C Daskalakis RJ Weigel 2005 GATA-3 expression as a predictor of hormone response in breast cancer J Am Coll Surg 200 705 710 10.1016/j.jamcollsurg.2004.12.025
11. J Usary V Llaca G Karaca S Presswala M Karaca X He A Langerod R Karesen DS Oh LG Dressler PE Lonning RL Strausberg S Chanock AL Borresen-Dale CM Perou 2004 Mutation of GATA3 in human breast tumors Oncogene 23 7669 7678 10.1038/sj.onc.1207966
12. M Garcia-Closas MA Troester Y Qi A Langerod M Yeager J Lissowska L Brinton R Welch B Peplonska DS Gerhard IT Gram V Kristensen AL Borresen-Dale S Chanock CM Perou 2007 Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status Cancer Epidemiol Biomarkers Prev 16 2269 2275 10.1158/1055-9965.EPI-07- 0449
13. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dork T, Schurmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomaki K, von Smitten K, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengstrom M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Australian Ovarian Cancer Management G, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast C, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Klijn JG, Hooning MJ, Meijers-Heijboer H, Collee JM, van den Ouweland A, Uitterlinden AG, Liu J, Lin LY, Yuqing L, Humphreys K, Czene K, Cox A, Balasubramanian SP, Cross SS, Reed MW, Blows F, Driver K, Dunning A, Tyrer J, Ponder BA, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gabrieau V, Sigurdson A, Doody M, Struewing JP, Alexander B, Easton DF, Pharoah PD (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4:e1000054. doi: 10.1371/journal.pgen.1000054
14. C Breast Cancer Association 2006 Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium J Natl Cancer Inst 98 1382 1396
15. AC Antoniou AB Spurdle OM Sinilnikova S Healey KA Pooley RK Schmutzler B Versmold C Engel A Meindl N Arnold W Hofmann C Sutter D Niederacher H Deissler T Caldes K Kampjarvi H Nevanlinna J Simard J Beesley X Chen SL Neuhausen TR Rebbeck T Wagner HT Lynch C Isaacs J Weitzel PA Ganz MB Daly G Tomlinson OI Olopade JL Blum FJ Couch P Peterlongo S Manoukian M Barile P Radice CI Szabo LH Pereira MH Greene G Rennert F Lejbkowicz O Barnett-Griness IL Andrulis H Ozcelik AM Gerdes MA Caligo Y Laitman B Kaufman R Milgrom E Friedman SM Domchek KL Nathanson A Osorio G Llort RL Milne J Benitez U Hamann FB Hogervorst P Manders MJ Ligtenberg AM van den Ouweland S Peock M Cook R Platte DG Evans R Eeles G Pichert C Chu D Eccles R Davidson F Douglas AK Godwin L Barjhoux S Mazoyer H Sobol V Bourdon F Eisinger A Chompret C Capoulade B Bressac-de Paillerets GM Lenoir M Gauthier-Villars C Houdayer D Stoppa-Lyonnet G Chenevix-Trench DF Easton 2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 937 948 10.1016/j.ajhg.2008.02.008
16. EL Korn BI Graubard D Midthune 1997 Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale Am J Epidemiol 145 72 80
17. AC Antoniou DE Goldgar N Andrieu J Chang-Claude R Brohet MA Rookus DF Easton 2005 A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes Genet Epidemiol 29 1 11 10.1002/gepi.20074
18. DY Lin LJ Wei 1989 The Robust Inference for the Cox Proportional Hazards Model J Am Stat Assoc 84 1074 1078 10.2307/2290085
19. SR Lakhani JS Reis-Filho L Fulford F Penault-Llorca M van der Vijver S Parry T Bishop J Benitez C Rivas YJ Bignon J Chang-Claude U Hamann CJ Cornelisse P Devilee MW Beckmann C Nestle-Kramling PA Daly N Haites J Varley F Lalloo G Evans C Maugard H Meijers-Heijboer JG Klijn E Olah BA Gusterson S Pilotti P Radice S Scherneck H Sobol J Jacquemier T Wagner J Peto MR Stratton L McGuffog DF Easton 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 5175 5180 10.1158/1078-0432.CCR-04-2424
20. H Kouros-Mehr JW Kim SK Bechis Z Werb 2008 GATA-3 and the regulation of the mammary luminal cell fate Curr Opin Cell Biol 20 164 170 10.1016/j.ceb.2008.02.003